Pieris Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
PIRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
225 Franklin Street, 26 Th Floor, Boston, MA

Insiders trading volume in the past year

Pieris Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ADAR1 Capital Management, LLC 10%+ Owner $2.3M +$92.3K +4.19% Aug 9, 2024
Bvf Partners L P/Il 10%+ Owner $633K May 11, 2023
Christopher P. Kiritsy Director $17K Jun 21, 2023
Tim Demuth Chief Medical Officer $5.1K May 13, 2022
Ann Barbier Director Jun 21, 2023
Maya R. Said Director Jun 21, 2023
Shane Olwill Chief Development Officer Feb 24, 2023
Ahmed Mousa Chief Business Officer Feb 24, 2023
Stephen S. Yoder Chief Executive Officer, Director Feb 24, 2023
Hitto Kaufmann Chief Scientific Officer Feb 24, 2023
Thomas Bures Chief Financial Officer Feb 24, 2023
Peter Kiener Director Jun 21, 2023
James A. Geraghty Director Jun 21, 2023
Michael Richman Director Jun 21, 2023
Matthew L. Sherman Director Jun 21, 2023

Recent Insider Transactions by Companies or Individuals for Pieris Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.